Encompass Health Co. (NYSE:EHC) Given Consensus Rating of “Buy” by Analysts

Shares of Encompass Health Co. (NYSE:EHC) have been assigned an average recommendation of “Buy” from the eleven research firms that are covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $107.11.

Several research firms recently issued reports on EHC. UBS Group lifted their price objective on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. Barclays boosted their price target on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. KeyCorp raised their price objective on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Truist Financial reaffirmed a “buy” rating and set a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Finally, Royal Bank of Canada increased their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th.

Institutional Investors Weigh In On Encompass Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Oliver Luxxe Assets LLC increased its position in shares of Encompass Health by 4.8% during the 4th quarter. Oliver Luxxe Assets LLC now owns 63,453 shares of the company’s stock worth $5,860,000 after purchasing an additional 2,900 shares during the last quarter. Nordea Investment Management AB increased its position in shares of Encompass Health by 5.2% during the fourth quarter. Nordea Investment Management AB now owns 94,514 shares of the company’s stock valued at $8,797,000 after acquiring an additional 4,714 shares during the last quarter. Central Pacific Bank Trust Division raised its stake in shares of Encompass Health by 15.1% in the 4th quarter. Central Pacific Bank Trust Division now owns 3,195 shares of the company’s stock valued at $295,000 after acquiring an additional 418 shares during the period. Everence Capital Management Inc. acquired a new position in shares of Encompass Health in the 4th quarter worth approximately $253,000. Finally, GAMMA Investing LLC boosted its position in shares of Encompass Health by 22.1% during the 4th quarter. GAMMA Investing LLC now owns 1,947 shares of the company’s stock worth $180,000 after purchasing an additional 352 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC stock opened at $91.19 on Tuesday. The company has a market capitalization of $9.19 billion, a P/E ratio of 22.03, a P/E/G ratio of 1.30 and a beta of 0.89. Encompass Health has a 12-month low of $67.12 and a 12-month high of $104.55. The business’s 50 day moving average is $98.86 and its two-hundred day moving average is $93.58. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm’s revenue was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.86 EPS. Analysts expect that Encompass Health will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio is presently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.